Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Effectiveness of nilvadipine in two cases of chronic schizophrenia.

Yamada K, Ashikari I, Onishi K, Kanba S, Yagi G, Asai M.

Psychiatry Clin Neurosci. 1995 Aug;49(4):237-8.

PMID:
9179944
[PubMed - indexed for MEDLINE]
2.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
[PubMed - indexed for MEDLINE]
3.

[New chemotherapy approaches to psychoses].

Olié JP, Baylé FJ.

Encephale. 1997 Apr;23 Spec No 2:2-9. Review. French.

PMID:
9273302
[PubMed - indexed for MEDLINE]
4.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
5.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
[PubMed - indexed for MEDLINE]
6.

[Central effect of calcium channel antagonists: new therapeutic possibilities in neurology and psychiatry?].

Kostowski W, Puciłowski O.

Psychiatr Pol. 1990 May-Jun;24(3):209-16. Review. Polish. No abstract available.

PMID:
2084729
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk